Apricity raises £5.4m Series A funding from Kamet Ventures to accelerate commercial expansion.
The London based virtual fertility clinic secured Series A backing from AXA division Kamet Ventures to scale its operations.
Apricity operates a virtual fertility clinic that combines reproductive medicine with proprietary mobile technology and artificial intelligence. The firm offers personalised patient support and treatment tracking to improve conception rates.
Apricity has secured £5.4m in a Series A funding round led by Kamet Ventures, a venture builder backed by AXA. The capital will be deployed to accelerate go to market strategies and expand its digital fertility services following its recent acquisition of egg donation provider Altrui.
The London based virtual fertility clinic combines medical expertise with artificial intelligence through a dedicated mobile application designed to streamline the fertility treatment process. This latest injection brings the total capital raised by the company to over £7m, positioning it to address growing pressures on reproductive healthcare services.
From the founder
"We are thrilled that for such a new company, we have seen such amazing support from AXA and Kamet Ventures,"
Caroline Noublanche
Founder and CEO at Apricity
Investor perspective
"For too long, women and couples undergoing fertility services have grappled with a system that fails to acknowledge or respond to the practical and psychological pressures they face,"
Stéphane Guinet
CEO, Kamet Ventures
Use of funds
- 01Accelerate go-to-market